Company Filing History:
2 out of 1,373 
2 out of 2,963 
1 out of 1,036 
Years Active: 2011-2015
Title: Scott Weiss: Innovator in Genetic Research
Introduction
Scott Weiss is a prominent inventor based in Chestnut Hill, MA (US), known for his significant contributions to the field of genetic research. He holds three patents that focus on diagnosing and predicting respiratory diseases, particularly in individuals with cystic fibrosis and asthma. His work has the potential to greatly impact patient care and treatment strategies.
Latest Patents
One of Scott Weiss's latest patents is a method for determining predisposition to pulmonary infection. This invention provides methods and materials for diagnosing a subject's predisposition for pulmonary infection in cystic fibrosis patients by detecting specific genetic markers. The pulmonary infection markers identified in the IL-1 gene cluster may be instrumental in predicting disease progression and assessing a patient's response to therapy. Another notable patent involves genetic analyses predictive of asthma. This invention focuses on genetic sequence variations that can indicate whether a person is likely to develop asthma, particularly when certain polymorphic forms of the CCL11 gene, CCL2 gene, and TLR7 gene are present.
Career Highlights
Throughout his career, Scott Weiss has made significant strides in the medical research community. His work has been instrumental in advancing the understanding of genetic factors that contribute to respiratory diseases. He has been affiliated with reputable institutions, including The Brigham and Women's Hospital, Inc. and Harvard College, where he has conducted extensive research.
Collaborations
Scott Weiss has collaborated with notable professionals in his field, including Hara Levy and Craig J Gerard. These collaborations have further enriched his research and contributed to the development of innovative solutions in genetic diagnostics.
Conclusion
Scott Weiss is a distinguished inventor whose work in genetic research has the potential to transform the diagnosis and treatment of respiratory diseases. His patents reflect a commitment to advancing medical science and improving patient outcomes.